HKCEM College Tutorial
AUTHOR
DR. LAU CHU LEUNG, TERRY
NOV., 2013
▪ M/65 Chronic smoker
▪ SOB for 2 days
▪ Increased when lying supine
▪ Headache, facial swelling
▪ BP 178/84 mmHg
▪ Pulse 124 bpm
▪ RR 20 /min, SpO2 97% RA
▪ T - 37.3 ºC
▪ Issue(s) identified?
▪ HT
▪ Tachypnea
▪ Tachycardia
▪ DDx of SOB?
▪ COPD
▪ CHF
▪ Asthma
▪ APO
▪ Pneumothoax
▪ Upper airway obstruction
▪ Any red flags of headache?
▪ ABC - secure airway if necessary
▪ Oxygen
▪ Set intravenous access
▪ Monitoring – BP/P, SpO2, cardiac monitor
▪ While you get further history from patient, you notice…
▪ What are the DDx of SOB with dilated neck veins?
▪ SOB + Dilated neck veins
▪ Congestive heart failure
▪ Right ventricular infarct
▪ Superior vena cava obstruction
▪ Cardiac tamponade
▪ Constrictive pericarditis
▪ Tension pneumothorax
▪ Massive haemothorax
▪ Massive pulmonary embolism
▪ Facial Swelling
▪ Nephrotic syndrome
▪ Cellulitis
▪ Angioedema
▪ Myxedema
▪ Moon face (chronic steroids)
▪ Superior vena cava obstruction
▪ Melkersson-Rosenthal Syndrome orofacial edema
▪ Conglomeration of s/s that results from compression or occlusion of the SVC
▪ SVC receives venous drainage from H&N,
UL
▪ Thin walled extremely susceptible to extrinsic compression
▪ Immediately life-threatening oncologic emergency if airway compromise or CNS symptoms are present
▪ Dilatation of the two external jugular veins
▪ Increasing symptoms when the patient is in a horizontal position
▪ Malignant (90%)
▪ Ca bronchus
▪ Small-cell lung cancer (SCLC)
▪ Non-small-cell cancer (NSCLC)
▪ Lymphoma
▪ Metastatic disease
▪ Germ-cell cancer
▪ Thymoma
▪ Mesothelioma
▪ Benign (10%) - compression, infiltration, thrombosis
▪ Indwelling central venous catheters
▪ Thoracic aortic aneurysm (ascending)
▪ Substernal goiter
▪ Constrictive pericarditis
▪ Primary thrombosis
▪ Idiopathic sclerosing aortitis
▪ Fibrosing mediastinitis
▪ Radiation
▪ Arteriosclerotic
▪ Infection - TB mediastinitis, luetic (syphilitic) aneurysm, histoplasmosis
▪ What are the common presentations?
▪ Physical signs?
▪ Facial edema, plethora
▪ Jugular venous distention
▪ Prominent superficial vascularity
▪ Neck & upper chest
▪ Stokes sign – tightness of shirt collar
▪ Edema of larynx or pharynx
▪ Hoarseness, stridor
▪ Cerebral edema, increased ICP
▪ Papilledema
▪ Confusion, coma
▪ Early symptoms
▪ Edema of face, neck, UL
▪ SOB
▪ Venous distension of upper chest, neck and face
▪ Ruddy complexion (Plethora)
▪ Dysphagia
▪ Chest pain
▪ Late symptoms
▪ Severe respiratory distress
▪ Cyanosis
▪ Headache
▪ Visual disturbances
▪ Coma
▪ Convulsions
▪ Death
▪ Pemberton Sign
▪ Exaggeration of edema and flushing with placement of the patient’s arms overhead
▪ Indicates compression of vascular structures in the thoracic inlet
▪ Highly indicative of SVCO
▪ Substernal goitre
▪ Recognition of life-threatening symptoms - airway compromise and/or cerebral edema
▪ Confirmation of the presence of venous obstruction
▪ Imaging +/- interventions to establish the etiology
▪ Relief obstruction
▪ Treatment of the underlying cause
▪ Revise your Mx? Any precautions?
▪ Propped up position
▪ Elevate patient's head hydrostatic pressure (edema)
▪ Potential difficult airway
▪ Cannot lie flat
▪ Edematous epiglottis and vocal cords and narrowed glottic opening
▪ Mediastinal tumour
▪ Superior Mediastinal Syndrome – SVCO + tracheal compression
▪ Should be considered in lower limbs in the case of complete SVC obstruction
▪ With partial obstruction, upper limb access is acceptable
▪ UL iv access delays in resuscitation fluids and drugs reaching the central circulation
▪ Induction time will be prolonged
▪ Overdose is a potential risk
▪ In the absence of major bleeding / hypotension, fluid restriction is the watchword
▪ Diuretics must be used judiciously to avoid hypovolemia
▪ Glucocorticoid therapy (dexamethasone, iv 4 mg Q6H)
▪ Work mainly by reducing tumour and airway oedema
▪ Benefits documented only in case studies
▪ Generally used in conjunction with radiotherapy because of concern about radiationinduced oedema
▪ Reduce tumor burden in lymphoma & thymoma reduce obstruction
▪ Risk
▪ Obscuring the tissue diagnosis, especially if lymphoma is suspected
▪ Steroid-induced acute tumour lysis syndrome
▪ Confirming the diagnosis of SVCO
▪ Identify the site and extent of the occlusion
▪ Presence of intravascular thrombus and collateral circulations
▪ Presence of collateral vessels is highly suggestive of SVCO
▪ Sensitivity of 96% and a specificity of 92%
▪ Identify its underlying cause
▪ Planning treatment
▪ Information on the length of the lesion
▪ Any involvement of the brachiocephalic veins
▪ Signs of the development of collateral circulation
▪ Opacity above the right stem bronchus dilation of the arch of the azygos
▪ Sub-aortic opacity or ‘‘ aortic nipple’’ sign dilation of the left superior intercostal vein
▪ Neck mass – substernal goitre
▪ Superior mediastinal widening
▪ Hilar mass - bronchogenic carcinoma
▪ Anterior mediastinal mass – lymphoma
▪ Calcification – Histoplasmosis
▪ Pleural/pericardial effusion
▪ Small-cell lung cancer
(a) Axial CT - Large right hilar mass obstructing SVC
Multiple chest wall collateral vessels
(b) Coronal CT - Compression of SVC distally (arrow)
Thrombosis of proximal SVC and brachiocephalic veins
(c) 3D CT - appearance of multiple collaterals of chest wall
▪ 4-cm thrombus in the SVC
▪ Invasive venography - gold standard
▪ Carried out prior to stenting to delineate the presence of an SVC stenosis or occlusion, and to identify the extent of the obstruction
▪ Cannot be performed in isolation, as it cannot identify the cause of the obstruction
▪ Simultaneous bilateral arm venogram
▪ Defines obstruction and collateral circulation
▪ Identifies thrombus
▪ Figure
▪ severe compression of both the right and left subclavian veins (RSV and LSV)
▪ a thrombus in the left subclavian vein
▪ multiple venous collaterals
▪ Advantages
▪ Rapid relief of the symptoms of venous congestion
▪ Relief can be immediate, but in most series, it is reported within 24 to 72 hours following the procedure
▪ Allowing treatment of underlying pathology to be initiated
▪ Stent can be placed before a tissue diagnosis is available
▪ Allows early cisplatin based chemotherapy to commence (requires hydration)
▪ Prevent the risk of death due to laryngeal or bronchial oedema
▪ Indications
▪ Symptomatic malignant SVCO
▪ Symptomatic benign SVCO
▪ known chemotherapy and radiation-resistant tumors
▪ No absolute contraindications to SVC stenting
▪ Relative contraindications
▪ Patient cannot lie flat or semisupine on the table
▪ Patient with malignancy with a very good chance of cure or remission
▪ Complications 3-7%
▪ Stent migration
▪ Bleeding
▪ Infection
▪ Thrombosis (Figure: Reocclusion of the stent by thrombus on an (a) axial CT and (b) coronal CT)
▪ SVC rupture
▪ Pericardial tamponade
▪ Hematoma at insertion site
▪ Acute tumour lysis syndrome
▪ Late complications
▪ Bleeding (1-14%), death (1-2%)
▪ In the absence of a need for urgent intervention, the management should focus initially on establishing the correct diagnosis
▪ Treatment is directed at the underlying pathological process
▪ When malignancy is suspected without known primary cancer tissue biopsy
▪ Sputum cytology
▪ Pleural fluid analysis
▪ Excisional LN biopsy
▪ Bone marrow
▪ Bronchoscopy with transbronchial needle aspiration
▪ Urgent treatment with radiotherapy and corticosteroids should be used only for lifethreatening situations
▪ Stridor, hypotension, collapse
▪ Stenting is becoming increasingly used
▪ Useful procedure for patients with severe symptoms such as respiratory distress that require urgent intervention
▪ No evidence to support routine anticoagulation in patients with malignant SVCO in the absence of thrombosis
▪ After a tissue diagnosis has been obtained and the extent of the disease has been determined, a decision should be made to address control of the malignant process in either a curative fashion or palliatively
▪ Radiation, chemotherapy, or stent placement, or a combination of these modalities
▪ Chemotherapy responsive tumour
▪ Non-Hodgkin lymphomas, small cell lung cancer, and germ cell tumors are widely regarded as chemotherapysensitive tumors
▪ Good prognosis - high rates of response and quick onset of tumor shrinkage
▪ Less responsive tumours - non-small cell lung cancer, B-cell lymphoma
▪ Stents or RT/chemotherapy
▪ Relative contraindications
▪ Previous treatment with radiation in the same region
▪ Certain connective tissue disorders - scleroderma
▪ Known radioresistant tumor types – sarcoma
▪ Majority of tumor types are sensitive
▪ Improvement is often apparent within 72 hours
▪ Thymomas are relatively resistant to chemotherapy and radiation Surgery
▪ Bypass grafting using an autologous vein graft or a synthetic tube
▪ Good patency rates (80–90%)
▪ Major surgical procedure that requires careful patient selection
▪ High morbidity and 5% mortality rate
▪ More insidious course development of adequate collaterals
▪ Treatment is usually directed at the underlying cause
▪ Medical management with diuretics and steroids NOT useful
▪ If symptoms caused by thrombus formation
▪ Thrombolysis followed by anticoagulation with heparin or warfarin
▪ Less effective in chronic thrombosis (with onset of symptoms more than 10 days previously)
▪ If symptoms develop rapidly
▪ SVC bypass surgery
▪ Endovascular stenting
▪ Result from indwelling vascular hardware
▪ No evidence that removing the catheter in the ED provides any benefit
▪ Anticoagulation
▪ Percutaneous transluminal angioplasty +/- metallic stent
▪ SVCO may coexist with pulmonary embolism
▪ Superior mediastinal syndrome
▪ Rubin Syndrome – SVCO + spinal cord compression
▪ Steroid-induced acute tumour lysis syndrome
▪ ‘‘Overload syndrome’’
▪ Opening of a SVC stenosis inducing a fast cardiac return of the third compartment
(oedema) may generate an ‘‘overload syndrome’’ with pre-capillary pulmonary hypertension and pulmonary oedema
▪ Increased intracranial pressure
▪ Spontaneous intracranial hemorrhage
▪ Postgrad Med J 2013;89(1050):224–30
▪ Journal of Clinical Neuroscience 2013;20:1040–1
▪ Q J Med 2013;106:283–4
▪ Rosen’s Emergency Medicine 8th ed.
▪ Journal of Emergency Medicine 2012;43(6):1079–80
▪ South Afr J Anaesth Analg 2012;18(1):20-4
▪ BMJ 2011;343:d4466
▪ Visual Diagnosis in Emergency and Critical Care Medicine (2011)
▪ Ann Emerg Med. 2010;56:305
▪ Emerg Med Clin N Am 2009;27:243–55
▪ Irwin and Rippe’s Intensive Care Medicine (2008)
▪ NEJM 2007;356(18):1862-9
▪ Critical Care – Just the facts (2007)
▪ NEJM 2006;354 (8): e7
▪ Can J Emerg Med 2005;7(4):273-7